Aptatek Biosciences is a developing a portable disease management device that detects
small molecules otherwise only detectable in a lab, starting with PKU.
small molecules otherwise only detectable in a lab, starting with PKU.
Employees: 11-50
Total raised: $4M
Investors 1
| Date | Name | Website |
| - | IP Group N... | ipgroup-in... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.03.2022 | Seed | $4M | - |
Mentions in press and media 2
| Date | Title | Description |
| 19.06.2024 | Aptatek BioSciences Closes Funding | Aptatek BioSciences, a Princeton, NJ-based developer of in-home health monitoring solutions for patients with chronic disease, raised an undisclosed amount in funding based on the successful initial clinical evaluation of its first product.... |
| 18.03.2022 | Aptatek BioSciences Closes $4M Seed Funding | Aptatek BioSciences, a Princeton, NJ-based provider of in-home health monitoring solutions, raised $4M in Seed funding. The round was led by IP Group, Inc., Canterbury Scientific Limited, and National PKU Alliance. A spinout from Columbia U... |